The series is stated in the current share scale after splits; dividends are not included in the price
Humana insures the elderly through Medicare Advantage — almost its entire business depends on one government programme.
The government pays the insurer a fixed sum per enrolled pensioner, and the insurer arranges care. Profit arises when actual costs fall below that sum. The key metric is the share of premiums spent on claims: a couple of points of increase removes the profit entirely.
That is precisely what happened: after the pandemic the elderly sought deferred care more often, costs outran rates, and the industry moved into loss on some plans. A second factor is the plan quality rating, which determines a payment bonus; a downgrade costs the company hundreds of millions. Enrolment growth and margin now pull in opposite directions: signing more members raises costs before it raises payment. Humana pays a dividend.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Humana Inc. (HUM) is a company in the Health care sector; its shares trade on NYSE.
The price of Humana Inc. (HUM) on November 2, 2026 is 403.00 $, −2.77 % on the day. Over 52 weeks the stock traded between 163.11 $ and 456.50 $; the price now sits 82 % of the way up that range. Over the past year the price changed by +64.85 %. The P/E ratio is 38.57, which is above the sector median (24.61). Market capitalization is 49.33 billion $, rank 4 among 9 stocks of the same industry with a known capitalization.
Humana Inc. trades on NYSE under the ticker HUM. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks HUM has traded between 163.11 $ and 456.50 $. As of 2 November 2026 the price stood 91.72 % of the way from the 52-week low to the high.
Over one year HUM shares rose 64.85 %; over six months they rose 115.28 %. Volatility over 90 days is 37.74 %. Dividends are not included: this is price change only, as of 2 November 2026.
HUM trades at a price-to-earnings ratio of 38.6, above the sector median of 24.6. Price to sales is 0.3, below the sector median of 3.6. Price to book is 2.6, above the sector median of 2.5. Calculated from reports for the period ending 30 June 2026.
Humana Inc. reported revenue of 145.7B $ and net income of 1.3B $ over the last four quarters. Net margin is 0.88 %. Revenue changed by +18.33 % year over year. Earnings per share are 10.58 $. Market capitalisation is 49.3B $.
HUM has a return on equity of 6.66 %, above the sector median of −40.58 %. Return on assets is 2.24 %, above the sector median of −30.08 %. Operating margin is 1.86 %, above the sector median of −20.96 %.
